The Inhibition of Group II Innate Lymphoid Cell Response by IL-27 in Allergic Rhinitis

Figure 1

The serum expression of IL-27 and the proportion of ILC2 in PBMCs between AR and controls. (a, b) Expression of serum IL-27 mRNA and protein levels between AR and controls by polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. (c) Frequency of ILC2 in PBMCs between controls and AR as well as isotype and FMO controls by flow cytometry. AR: allergic rhinitis; FMO: fluorescence minus one; HC: healthy control; ILC2: group II innate lymphoid cells; PBMC: peripheral blood mononuclear cells.

(a)

(b)

(c)

(d)